Louis G. Lange, Director at NewAmsterdam Pharma Co N.V. (NAMS), sold 44,619 shares at $30.41 ($1.4M) on 2026-03-11, disclosed to the SEC on 2026-03-12.
Open-market sale of $1.4M NAMS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.41 | 44,173 | $1.3M | 99.0% |
| 2 | $31.23 | 446 | $14K | 1.0% |
| Total | $30.42 avg | 44,619 | $1.4M | 100% |
| Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |
| BOLD | SELL | 2019-06-26 | $1.5M | — | Filing → |